loader

nasdaq:blph

LATEST ARTICLES

Bellerophon Announces Agreement with FDA on Regulatory Approval Pathway for INOpulse

Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint

NASDAQ:AXSM

5 Top Weekly NASDAQ Biotech Stocks: Index Up During JPM Week

NASDAQ:AKAO

5 Top Weekly NASDAQ Biotech Stocks: Innovate Leads the Pack

NASDAQ:ATXI

5 Top Weekly NASDAQ Biotech Stocks: Cocrystal on Top

NASDAQ:BLPH

Bellerophon Updates Ongoing Phase 2b Trial

Bellerophon Provides Update on INOpulse Phase 2b Clinical Program for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

NASDAQ:BLPH

5 Top Weekly NASDAQ Biotech Stocks: Molecular Templates on Top

ASX:AVH

VIDEO - Life Science Update August 2018

NASDAQ:BLPH
pharmaceutical investing

Bellerophon Halts Phase 3 Trial

Bellerophon Announces Results of Interim Analysis of Phase 3 INOvation-1 Study Evaluating INOpulse for Treatment of Pulmonary Arterial Hypertension

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES